source
- Poll Findings Highlight the Most Anticipated GU Cancer Abstracts at ASCO 2026GU experts identified key abstracts of interest from the upcoming ASCO Annual Meeting via OncLive’s social media.onclive · 2mo ago↗ source
- Aardvark's next move after clinical hold; Alumis' verdict on Acelyrin assetPlus, news about Tenaya’s TN-401 and Taiho’s Inqovi. 📉 Aardvark to unblind rare disease trial following clinical hold: The FDA has placed a full clinical hold on the company's candidate for ...Endpoints · 2mo ago↗ source
- India’s pharma industry is going global. But can it catch up to China?A record Sun Pharma acquisition signals global ambitions. But infrastructure, capital and policy gaps could stand in the way of India becoming an R&D powerhouse.BioPharma Dive